Recent developments in tau-based therapeutics for neurodegenerative diseases.
about
New Features about Tau Function and DysfunctionImplications of protein structure instability: from physiological to pathological secondary structure.Tolfenamic acid reduces tau and CDK5 levels: implications for dementia and tauopathies.Use of okadaic acid to identify relevant phosphoepitopes in pathology: a focus on neurodegenerationThe role of extracellular Tau in the spreading of neurofibrillary pathology.Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.Understanding the relationship between GSK-3 and Alzheimer's disease: a focus on how GSK-3 can modulate synaptic plasticity processes.Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward.Further understanding of tau phosphorylation: implications for therapy.Deconstructing GSK-3: The Fine Regulation of Its Activity.An Overview on the Clinical Development of Tau-Based Therapeutics.Monoclonal antibodies against β-amyloid (Aβ) for the treatment of Alzheimer's disease: the Aβ target at a crossroads.
P2860
Q26750922-DA8F4F02-17AB-4DE4-86E4-B7D7F868D546Q30416896-E5C0E623-7837-4D67-A74E-2185F2EE92E3Q35264520-E0E70C01-337F-4946-A3FC-ADC6CEB6DEC6Q36999161-2134EA07-39F9-4E4C-AAFA-13CA3607206CQ37734856-1F7250AE-DD5C-4BF5-A377-568E0E3FA030Q37984574-80B8CD03-E04F-4A73-A7B7-B23E75C60E69Q38101982-08C237A7-AC9A-4318-AE43-53703AF709F3Q38184618-1EC03901-6D4F-4E8D-A12B-38284804FECFQ38306065-F2C9EA2B-ED1B-4F12-84F0-D6437B42A7C6Q42135408-7FE04AC3-EFBD-45C6-BB13-A8F78A5B874FQ52594209-438CB2FD-AF0B-421C-A738-CDBF8D895CEAQ53318372-A1D79C13-5D33-4E6E-A045-39D50828E0D8
P2860
Recent developments in tau-based therapeutics for neurodegenerative diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recent developments in tau-based therapeutics for neurodegenerative diseases.
@en
Recent developments in tau-based therapeutics for neurodegenerative diseases.
@nl
type
label
Recent developments in tau-based therapeutics for neurodegenerative diseases.
@en
Recent developments in tau-based therapeutics for neurodegenerative diseases.
@nl
prefLabel
Recent developments in tau-based therapeutics for neurodegenerative diseases.
@en
Recent developments in tau-based therapeutics for neurodegenerative diseases.
@nl
P1476
Recent developments in tau-based therapeutics for neurodegenerative diseases.
@en
P356
10.2174/157488911794079091
P577
2011-01-01T00:00:00Z